Therapy Analysis & Statistics, November 2012 (p30)

Northwest Biotherapeutics, Inc. (Symbol:NWBO) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Therapy
Countries : United States, Germany

Ark Therapeutics Group plc (Symbol:AKT) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Therapy
Countries : Finland, United States, United Kingdom

Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review

$ 125
Company report
November 2012
by Global Data

Summary Cytori Therapeutics, Inc. (Cytori) develops, manufactures, and commercializes innovative medical devices that enables physicians to practice regenerative medicine worldwide. Cytori has three key ...

Industries : Therapy

Celldex Therapeutics, Inc. (Symbol:CLDX) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Therapy
Countries : United States

Laboratorios Del Dr. Esteve S.A. - Strategic SWOT Analysis Review

$ 125
Company report
November 2012
by Global Data

Summary Laboratorios Del Dr. Esteve S.A. (ESTEVE) is a international pharmaceutical company that conducts research and development of new molecules, marketing, development and manufacturing of pharmaceuticals. ...

Industries : Therapy
Countries : United States, Mexico, Sweden, Spain, Italy, Germany, China

Talon Therapeutics, Inc. (TLON) - Financial and Strategic SWOT Analysis Review

$ 125
Company report
November 2012
by Global Data

Summary Talon Therapeutics, Inc. (Talon) is a biopharmaceutical company, which undertakes the research, development and commercialization of products for cancer therapy area. The company's product pipeline ...

Industries : Therapy
Countries : United States

Echo Therapeutics, Inc. (Symbol:ECTE) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Therapy
Countries : United States

Exonhit S.A. (ALEHT) - Financial and Strategic SWOT Analysis Review

$ 250
Company report
November 2012
by Global Data

Summary Exonhit S.A. (Exonhit) is a medical diagnostic company. It focuses on developing and marketing genomic profiling technology, diagnostic solutions and drugs. The company develops targeted innovative ...

Industries : Therapy

Disease and Therapy Review: Crohn%s Disease

$ 995
Industry report
November 2012
by Timely Data Resources Inc.

Abstract The Crohn's Disease Disease and Therapy Review provides an overview of the condition, with incidence and prevalence numbers for major countries worldwide, information on diagnosis, and an overview ...

Industries : Therapy
Countries : South Korea, World, Italy, Canada, Japan, Europe, North America, Australia, Singapore, United States, United Kingdom, Spain, France, Germany, China, Asia

Disease and Therapy Review: Melanoma

$ 995
Industry report
November 2012
by Timely Data Resources Inc.

Abstract The Melanoma Disease and Therapy Review provides an overview of skin cancer, with incidence, prevalence and mortality numbers, percentages and trends for major countries worldwide, and an overview ...

Industries : Therapy
Countries : Russian Federation, World, Philippines, Argentina, South Africa, Europe, Brazil, Mexico, Canada, Sweden, Spain, Poland, Italy, Greece, France, Germany, Thailand, South Korea, Japan, India, China, Egypt, Asia, Africa, United States, United Kingdom, South America, North America

BioMimetic Therapeutics, Inc. (Symbol:BMTI) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Therapy

Elekta AB (Symbol:EKTA B) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

Elekta AB (Elekta) is a medical technology company engaged in the development of advanced clinical solutions, comprehensive information systems and services for the management of brain disorders and improved ...

Industries : Therapy
Countries : Brazil

Disease and Therapy Review: Lung Cancer

$ 995
Industry report
November 2012
by Timely Data Resources Inc.

Abstract The Lung Cancer Disease and Therapy Review provides an overview of small cell and non-small cell lung cancer, with incidence, prevalence, and mortality numbers for major countries worldwide, information ...

Industries : Therapy
Countries : World, Russian Federation, Europe, Philippines, Argentina, South Africa, Brazil, Mexico, Canada, Spain, Poland, Italy, Greece, France, Germany, Thailand, Japan, India, China, Egypt, Asia, Africa, United States, United Kingdom, South America, Australia, Sweden, South Korea, North America

Disease and Therapy Review: Irritable Bowel Syndrome

$ 995
Industry report
November 2012
by Timely Data Resources Inc.

Abstract The Irritable Bowel Syndrome Disease and Therapy Review provides an overview of the condition, with prevalence numbers for major countries worldwide, information on diagnosis, and an overview ...

Industries : Therapy

Disease and Therapy Review: Senile Dementia

$ 995
Industry report
November 2012
by Timely Data Resources Inc.

Abstract The Senile Dementia Disease and Therapy Review provides an overview of the condition, with incidence and prevalence numbers for major countries worldwide, information on diagnosis, and an overview ...

Industries : Therapy
Countries : World

Disease and Therapy Review: Overactive Bladder

$ 995
Industry report
November 2012
by Timely Data Resources Inc.

Abstract The Overactive Bladder Disease and Therapy Review provides an overview of the condition, withprevalence numbers for major countries worldwide, information on diagnosis, and an overview of treatment. ...

Industries : Therapy
Countries : World, Europe, Spain, Italy, France, Germany, South Korea, Japan, United States, United Kingdom

Disease and Therapy Review: Multiple Sclerosis

$ 995
Industry report
November 2012
by Timely Data Resources Inc.

Abstract The Multiple Sclerosis Disease and Therapy Review provides and overview of the disease and its types, global patterns and incidence and prevalence numbers for major countries worldwide. Information ...

Industries : Therapy
Countries : World, Europe, Spain, Italy, France, Denmark, Taiwan, United States, Canada, United Kingdom, Germany, Japan, India, China, Asia, Africa

Symphogen A/S - Strategic SWOT Analysis Review

$ 125
Company report
November 2012
by Global Data

Summary Symphogen A/S (Symphogen) is a biopharmaceutical company. It develops antibody therapeutics such as monoclonal, monoclonal mixtures and polyclonal for the treatment of cancer, infectious and autoimmune ...

Industries : Therapy
Countries : United States, Denmark, Japan

IMRIS Inc. (Symbol:IM) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Therapy

Pharming Group N.V. (Symbol:PHARM) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Therapy
Countries : Netherlands

Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review

$ 125
Company report
November 2012
by Global Data

Summary Lorus Therapeutics Inc. (Lorus) is a biopharmaceutical company with focus on the discovery, research and development of anticancer therapies. It focuses in the development of treatments for several ...

Industries : Therapy
Countries : Canada

ARYx Therapeutics, Inc. - Financial and Strategic SWOT Analysis Review

$ 125
Company report
November 2012
by Global Data

Summary ARYx Therapeutics, Inc. (ARYx) is a biopharmaceutical company. It focuses on the discovery and development of novel oral therapies against chronic diseases. Its product pipeline comprises Tecarfarin ...

Industries : Therapy
Countries : United States

Amicus Therapeutics, Inc. (Symbol:FOLD) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Therapy
Countries : United States

GTC Biotherapeutics, Inc. (Symbol:GTCB) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Therapy
Countries : United States

Maxygen, Inc. (Symbol:MAXY) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Therapy
Countries : United States

Lincare Holdings Inc. (Symbol:LNCR) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Therapy
Countries : United States

Allos Therapeutics, Inc. (ALTH) - Financial and Strategic SWOT Analysis Review

$ 125
Company report
November 2012
by Global Data

Summary Allos Therapeutics, Inc., (Allos Therapeutics) a biopharmaceutical company, engaged in the development and commercialization of small molecule therapeutics for the treatment of cancer. Its lead ...

Industries : Therapy
Countries : United States

Global Radiation Therapy Equipment Industry

$ 4 950
Industry report
November 2012
by Global Industry Analyst

This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. ...

Industries : Therapy
Countries : World

Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market

$ 3 500
Industry report
November 2012
by GBI Research

Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market Summary ...

Industries : Therapy
Countries : World

Acute Lymphocytic Leukemia Therapeutics Market (Pipeline Forecast & Market Forecast in G8 Countries) (2010 - 2020)

$ 4 650
Industry report
November 2012
by MarketsandMarkets

The incidence of acute lymphocytic leukemia is high in children from 0 to 14 years than the people aged above 14. It is the most common childhood acute lymphocytic leukemia. However, the acute lymphocytic ...

Industries : Therapy
Countries : France, Canada, Spain, Italy, Germany, Japan, Europe, World, North America